Profile
| Metric | Value |
|---|---|
| Full Name | KALA BIO, Inc. |
| Ticker | NASDAQ: KALA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kalarx.com |
| Employees | 38 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.67 | |
| Price, 1D Change | +0.91% | |
| $5M | ||
| - | ||
| - | ||
| 1.15 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$10.15 | ||
| EPS, 1Y Change | +41.53% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:50 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$10.15 | ||
| EPS Estimate | N/A | -$4.45 |
| EPS Est. Change | N/A | +56.14% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.67 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$18.03 | -$17.35 | +3.76% | |
| -$11.07 | -$10.15 | +8.36% | |
| -$4.45 | N/A | +56.14% | |
| -$0.53 | N/A | +94.78% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.67 | |
| $4.87 | ||
| SMA 200 vs Price | +632.89% | |
| $0.73 | ||
| SMA 50 vs Price | +9.26% | |
| 1.15 | ||
| $0.13 | ||
| 43.61 | ||
| 112.17% | ||
| 158.73% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$10.15 | ||
| -$259.00K | ||
| - | ||
| -$40.43M | ||
| - | ||
| -$38.51M | ||
| - | ||
| -$40.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.62 | ||
| 3.11 | ||
| 3.11 | ||
| - | ||
| - | ||
| -18.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -0.63 | ||
| -0.35 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $12.33M | ||
| $51.18M | ||
| $55.48M | ||
| $52.80M | ||
| $43.15M | ||
| $16.96M | ||
| $32.25M | ||
| $10.72M | ||
| $628.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $38.51M | ||
| $40.18M | ||
| $259.00K | ||
| $0.00 | ||
| $259.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$29.38M | ||
| -$208.00K | ||
| $29.88M | ||
| $208.00K | ||
| -$29.59M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| Mizuho | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with KALA
Data Sources & References
- KALA Official Website www.kalarx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1479419/000155837025004081/0001558370-25-004081-index.htm
- KALA Profile on Yahoo Finance finance.yahoo.com/quote/KALA
- KALA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kala
FAQ
What is the ticker symbol for KALA BIO, Inc.?
The ticker symbol for KALA BIO, Inc. is NASDAQ:KALA
Does KALA BIO, Inc. pay dividends?
No, KALA BIO, Inc. does not pay dividends
What sector is KALA BIO, Inc. in?
KALA BIO, Inc. is in the Healthcare sector
What industry is KALA BIO, Inc. in?
KALA BIO, Inc. is in the Biotechnology industry
What country is KALA BIO, Inc. based in?
KALA BIO, Inc. is headquartered in United States
When did KALA BIO, Inc. go public?
KALA BIO, Inc. initial public offering (IPO) was on July 20, 2017
Is KALA BIO, Inc. in the S&P 500?
No, KALA BIO, Inc. is not included in the S&P 500 index
Is KALA BIO, Inc. in the NASDAQ 100?
No, KALA BIO, Inc. is not included in the NASDAQ 100 index
Is KALA BIO, Inc. in the Dow Jones?
No, KALA BIO, Inc. is not included in the Dow Jones index
When was KALA BIO, Inc. last earnings report?
KALA BIO, Inc.'s most recent earnings report was on May 13, 2025
When does KALA BIO, Inc. report earnings?
The date for KALA BIO, Inc.'s next earnings report has not been announced yet